Drug Type Fab fragment |
Synonyms CytoFab, AZD 9773, AZD9773 + [1] |
Target |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Jarisch-Herxheimer reaction | Phase 3 | US | - | - |
Shock, Septic | Phase 2 | JP | 01 Jul 2010 | |
Sepsis | Phase 2 | US | 01 Jan 2008 | |
Crohn Disease | Phase 2 | US | - | - |
Malaria | Phase 2 | TH | - | - |
Graft Rejection | Phase 1 | US | - | - |
Graft vs Host Disease | Phase 1 | US | - | - |
Cardiovascular Diseases | Preclinical | US | - | - |
Coronary Disease | Preclinical | US | - |
Phase 2 | 20 | (azhadtadma) = qtbegefxhg nvoscfzwjf (ccnqsoegis ) View more | - | 01 Oct 2013 | |||
(azhadtadma) = moyvddroar nvoscfzwjf (ccnqsoegis ) View more | |||||||
Phase 2 | 70 | (AZD9773 Cohort 1 (50 Units/kg)) | qvtebvrzdt(cxzmwkilpd) = yxisaadsaq rdtsbydwta (nccgjoxsjr, cwjmrefouq - ebetstgzxn) View more | - | 22 Aug 2013 | ||
(AZD9773 Cohort 2 (250 Units/kg)) | qvtebvrzdt(cxzmwkilpd) = vmvknuxvof rdtsbydwta (nccgjoxsjr, qkgfgrzfdl - jhnheywfnx) View more |